| Outcome Measures: |
Primary: Self reported quality of Life (CASP-19), All participants with treatment-related modification of quality of life as assessed by CASP-19, 6 months|The Diabetes Treatment Satisfaction (DTSQ), All participants with treatment-related self reported satisfation for diabetes therapy as assessed by DTSQ, 6 months | Secondary: Glycemic control, Glycaemic control evaluated by treatment-related modification of fasting glucose and HbA1c, 6 months|Hypoglycaemia, Self reported hypoglycaemic events rate, 6 months|Self reported depression (GDS), All participants with treatment-related modification of depression as assessed by GDS (Geriatric Depression Scale), 6 months|Hypoglycaemic related hospitalizations, Numbers of treatment-related hypoglycaemic hospitalizations, 6 months|Cognitive function (MMSE), All participants with treatment-related modification of cognitive function as assessed by Mini Mental State Examination (MMSE), 6 months
|
